0001104659-21-051156.txt : 20210416 0001104659-21-051156.hdr.sgml : 20210416 20210416090355 ACCESSION NUMBER: 0001104659-21-051156 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210415 FILED AS OF DATE: 20210416 DATE AS OF CHANGE: 20210416 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: De Paolantonio Ernest Robert CENTRAL INDEX KEY: 0001588538 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-08568 FILM NUMBER: 21830243 MAIL ADDRESS: STREET 1: 4131 PARKLAKE AVENUE SUITE 225 CITY: RALEIGH STATE: NC ZIP: 27612 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Teligent, Inc. CENTRAL INDEX KEY: 0000352998 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 010355758 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 LINCOLN AVENUE CITY: BUENA STATE: NJ ZIP: 08310 BUSINESS PHONE: 856.697.1441 MAIL ADDRESS: STREET 1: 105 LINCOLN AVENUE CITY: BUENA STATE: NJ ZIP: 08310 FORMER COMPANY: FORMER CONFORMED NAME: IGI LABORATORIES, INC DATE OF NAME CHANGE: 20100408 FORMER COMPANY: FORMER CONFORMED NAME: IGI INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOGENETICS INC DATE OF NAME CHANGE: 19870814 4 1 tm2113137-2_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-04-15 0 0000352998 Teligent, Inc. TLGT 0001588538 De Paolantonio Ernest Robert C/O TELIGENT, INC. 105 LINCOLN AVENUE BUENA NJ 08310 0 1 0 0 Chief Financial Officer Stock Option 0.57 2021-04-15 4 A 0 240000 0 A 2024-04-15 2031-04-15 Common Stock 240000 240000 D Restricted Stock Units 2021-04-15 4 A 0 195000 0 A 2022-04-15 2031-04-15 Common Stock 195000 195000 D The shares underlying the derivative securities shall vest on the third anniversary of the date of grant contingent upon (a) the Reporting Person's continued employment with the Registrant and (b) subject to achieving certain performance criteria. These securities were issued as an inducement to the Reporting Person to enter into employment with the Registrant. Each restricted stock unit represents the right to receive one share of the Issuer's common stock. One-fourth of the shares underlying the derivative securities shall vest ratably on an annual basis beginning on April 15, 2022 contingent upon the Reporting Person's employment with the Registrant. /s/ Ernest R. De Paolantonio 2021-04-16